Compare Bio Protocol (BIO) vs SUPRA (SUPRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs SUPRA — how do they compare? Bio Protocol trades at Rp439.85 (market cap Rp1T, Rp162,69M 24h volume), while SUPRA trades at Rp3.01 (market cap Rp98,56M, Rp5,32M 24h volume). The key difference: Bio Protocol is far larger — about 10146.1× SUPRA's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 32,7B / 100B SUPRA (33%) for SUPRA. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and SUPRA for 17 Days on average.
| BIO | SUPRA | |
|---|---|---|
Market Cap | Rp1T | Rp98,56M |
Volume (24h) | Rp162,69M | Rp5,32M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 32,7B / 100B SUPRA (33%) |
Typical Hold Time | 18 Days | 17 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
SUPRA is currently trading at Rp3.006 with a market cap of Rp98.21 million, exhibiting a strong bearish technical signal across moving averages and oscillators. The token's circulation rate is 33%, with an average hold time of 17 days. Current technical indicators show RSI levels in the oversold territory, suggesting potential for a short-term bounce, while ADX readings indicate a strong downtrend. No major protocol updates or ecosystem developments were identified in recent research.
The overall outlook remains cautious due to prevailing bearish momentum and limited fundamental catalysts. Key opportunities include potential oversold rebounds, while major risks involve low liquidity, high volatility, and the token's relatively small market capitalization making it susceptible to price swings. Investors should monitor for any significant ecosystem developments or changes in market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About SUPRA
Supra is the first blockchain built for Automatic DeFi (AutoFi), an automated financial system. As a Layer-1 solution, it supports high-speed smart contracts with integrated data and AI oracles, automation, and cross-chain messaging. This allows for innovative AutoFi features that generate revenue and redistribute it to applications and node operators, reducing reliance on block rewards over time. The Supra stack also provides AI agents with the tools needed to create and execute effective AutoFi strategies for users in a fully on-chain, secure, and autonomous manner.
Read more on SUPRA →
